Glenn M Marshall Selected Research

Immunotherapy

1/2023	A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.
11/2020	Withaferin A activates TRIM16 for its anti-cancer activity in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glenn M Marshall Research Topics

Disease

81	Neoplasms (Cancer) 11/2023 - 09/2003
72	Neuroblastoma 05/2024 - 03/2003
23	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 02/2003
19	Carcinogenesis 10/2023 - 07/2003
7	Leukemia 04/2024 - 06/2002
7	Breast Neoplasms (Breast Cancer) 09/2021 - 07/2003
6	Residual Neoplasm 08/2015 - 02/2003
4	Melanoma (Melanoma, Malignant) 11/2020 - 10/2014
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 09/2015
3	Neoplasm Metastasis (Metastasis) 08/2016 - 04/2014
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2014 - 02/2012
2	Hyperplasia 10/2023 - 08/2004
2	Skin Neoplasms (Skin Cancer) 09/2019 - 02/2012
2	Lung Neoplasms (Lung Cancer) 04/2014 - 05/2009
2	Infections 09/2012 - 10/2002
2	Glucocorticoid Receptor Deficiency 10/2010 - 05/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024
1	Neurofibrosarcoma (MPNST) 02/2021

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2003
12	Histone Deacetylase InhibitorsIBA 01/2023 - 06/2006
10	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 02/2010
10	Small Interfering RNA (siRNA)IBA 08/2016 - 10/2006
8	RetinoidsIBA 08/2015 - 03/2003
7	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2014
7	Vincristine (Oncovin)FDA LinkGeneric 10/2023 - 06/2002
7	EnzymesIBA 04/2021 - 09/2007
6	Messenger RNA (mRNA)IBA 12/2023 - 01/2014
6	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2014
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2014
6	Histone Deacetylases (Histone Deacetylase)IBA 01/2023 - 11/2007
6	Transcription Factors (Transcription Factor)IBA 09/2021 - 07/2010
6	N-Myc Proto-Oncogene ProteinIBA 01/2021 - 06/2011
6	Long Noncoding RNAIBA 11/2019 - 01/2014
4	Histones (Histone)IBA 01/2023 - 05/2006
4	Drug CombinationsIBA 01/2023 - 08/2016
4	Vorinostat FDA Link 01/2023 - 11/2012
4	PolyaminesIBA 04/2021 - 12/2008
4	Tripartite Motif ProteinsIBA 05/2016 - 02/2012
4	multidrug resistance-associated protein 1IBA 08/2009 - 01/2004
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2021 - 06/2007
3	Carrier Proteins (Binding Protein)IBA 11/2019 - 11/2009
3	Eflornithine (Ornidyl)FDA Link 01/2019 - 12/2008
3	Indicators and Reagents (Reagents)IBA 01/2018 - 02/2003
3	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 09/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015 - 05/2007
3	Folic Acid (Vitamin M)FDA LinkGeneric 06/2015 - 06/2010
3	Antisense OligonucleotidesIBA 07/2014 - 09/2003
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2006 - 03/2003
2	Ubiquitin-Specific ProteasesIBA 01/2023 - 01/2021
2	Adrenergic Agents (Adrenergic Drugs)IBA 10/2022 - 09/2021
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 06/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2009
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 04/2021 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2020 - 05/2007
2	Protein Isoforms (Isoforms)IBA 11/2020 - 02/2010
2	CrizotinibIBA 01/2020 - 01/2019
2	PanobinostatIBA 01/2019 - 01/2016
2	CationsIBA 01/2019 - 09/2016
2	VemurafenibIBA 08/2016 - 10/2014
2	Conditioned Culture MediaIBA 02/2016 - 11/2009
2	ChromatinIBA 11/2015 - 05/2009
2	Isotretinoin (Accutane)FDA LinkGeneric 08/2015 - 12/2012
2	VitaminsIBA 12/2014 - 06/2010
2	reversanIBA 08/2011 - 08/2009
2	Adenosine Triphosphate (ATP)IBA 08/2011 - 06/2010
2	Sirtuin 1IBA 06/2011 - 03/2009
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2010 - 05/2007
2	Protein Glutamine gamma Glutamyltransferase 2IBA 02/2010 - 11/2007
2	retinoic acid receptor betaIBA 05/2009 - 06/2006
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 05/2009 - 03/2003
2	TubulinIBA 02/2008 - 10/2006
2	LigandsIBA 12/2005 - 03/2003
1	JNJ-64619178IBA 12/2023
1	Antimitotic AgentsIBA 10/2023
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 10/2023
1	HydrogenIBA 03/2023
1	BromineIBA 03/2023
1	BenzimidazolesIBA 01/2023
1	ATP Translocases Mitochondrial ADPIBA 01/2023
1	benzimidazoleIBA 01/2023
1	pyrimidineIBA 01/2023
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2023
1	ruxolitinibIBA 11/2021
1	Mitogen-Activated Protein KinasesIBA 02/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021
1	lambda Spi-1IBA 01/2021
1	carfilzomibIBA 01/2021
1	UbiquitinIBA 01/2021
1	SE486-11IBA 01/2021
1	CateninsIBA 01/2021
1	OTX015IBA 01/2021
1	PolyubiquitinIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021

Therapy/Procedure

41	Therapeutics 04/2024 - 02/2003
17	Drug Therapy (Chemotherapy) 01/2023 - 02/2003
9	Precision Medicine 11/2023 - 01/2018
2	Immunotherapy 01/2023 - 11/2020
2	Stem Cell Transplantation 02/2015 - 09/2013
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Salvage Therapy 02/2021